SpaceX is public at $1.75 trillion. Now every space stock gets repriced.
Here's what matters for the next six months: a $1.75 trillion reference point just got planted in every institutional fund manager's spreadsheet, and most of them can't buy SpaceX at the size they want. The float is tight, the index inclusion timeline is uncertain, and the early buyers already hold the best positions. So where does the overflow go?
It goes to the handful of other public companies with real space exposure. That's a short list.
Rocket Lab USA (NASDAQ:RKLB) is the most obvious next stop. It is the only other company currently flying an operational orbital rocket on a commercial basis. Institutions that want launch exposure and can't get enough SpaceX have exactly one credible alternative on the open market. RKLB has been trading like a speculative small-cap for years. With a $1.75 trillion anchor now priced in the sector, that framing becomes harder to sustain.
AST SpaceMobile (NASDAQ:ASTS) runs a different angle. Its thesis is satellite-based cellular broadband delivered directly to ordinary smartphones, no special hardware required. Starlink proved the satellite connectivity model works at scale. ASTS is betting on the next evolution of it. A richly valued, publicly traded SpaceX legitimises the entire satellite connectivity category and pulls analyst coverage toward every credible player in the space.
Intuitive Machines (NASDAQ:LUNR) is the most direct SpaceX adjacency play. It flies its lunar landers on SpaceX rockets. It holds NASA contracts worth billions. When the sector leader re-rates, the companies closest to it in the supply chain tend to follow. LUNR is both a customer and a partner to the company the market just said is worth $1.75 trillion.
The contrarian pushback is worth taking seriously. Post-IPO sector enthusiasm has a habit of washing out fast, particularly when the anchor stock itself corrects after the listing euphoria fades. RKLB, ASTS, and LUNR are all still early-stage businesses burning cash. If SpaceX disappoints as a public company, the sympathy trade runs in reverse.
But the setup has a logic to it that goes beyond simple momentum. What the SpaceX IPO actually did was force institutional capital to build a framework for valuing space companies. Before June 2026, there was no public reference. Now there is one at $1.75 trillion. Every analyst covering RKLB, ASTS, and LUNR has to rebuild their model relative to that number. Some will move their price targets up. Some will initiate coverage for the first time. The research cycle alone creates buying pressure that wasn't there six months ago.
The window where these three trade as afterthoughts is probably closing. Whether the trade works depends on execution, burn rates, and whether SpaceX holds its valuation through its first few quarterly reports as a public company. Those are real risks. But the repricing mechanism is now in motion, and it has a specific catalyst with a specific date attached to it.
Three more stories worth knowing about